Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103

Summary

This study is an evaluation of the safety and tolerability of XEN-D0103 in healthy subjects. Part 1 assesses the safety, tolerability and blood levels of the ascending single doses of XEN-D0103. Blood levels of XEN-D0103 will be assessed when administered with food and also without food in Part 2. The safety, tolerability and blood levels of XEN-D0103 will be assessed following dosing for 10 days in Part 3.

Timeline

Start

2011-07

Primary completion

2011-12

Completion

2011-12

Drugs

Indications